Wednesday, November 27, 2024
As promised last week, I want to go back and explore the thesis advanced by KKR’s (KKR) macroeconomics team. Henry McVey and his team suggested that one of the best ways to earn high returns on your money over the next few years is going to be owning companies that are growing their free cash […]
In these early days of 2023, I often find myself thinking about how attractive Master Limited Partnership (MLP) investments look as we move into the year. After a great 2022, energy infrastructure companies are poised to perform well again this year. The big choice is whether to invest in midstream MLPs or shares of midstream […]
Utility stocks are historically seen as dull but dependable. After all, they have assured demand despite limits on profitability due to heavy regulation. Investors also see these stocks as regular dividend payers—bond proxies, in effect—with investors confident of solid income streams, leading to low but highly reliable total shareholder returns with relatively little capital risk. […]
For the last 5 years… with low interest rates… the only way to make money was investing in stocks. As you know, stocks have been volatile for the last few years. …big drop from Covid… …stocks rocket back… …equities peak end of 2021… …bear market in 2022 (and ongoing). But, right now, you can earn […]
There wasn’t a lot of meme stock action in 2022, but 2023 has been a different story so far. Bed Bath & Beyond (BBBY) has seen plenty of meme options action, and so has Carvana (CVNA), which appears to be the latest choice for meme stock traders. On a huge up day for the stock […]
I make no secret of the fact that I pay very close attention to what the big private equity (PE) and alternative asset managers are doing with their cash. I am frankly shocked that more people are not paying attention to what the giants of alternative investing, like KKR & Co. Inc. (KKR), Blackstone Inc. […]
My favorite among the major pharmaceutical companies remains AstraZeneca (AZN). One of the main reasons is that the company specializes in one of the areas where personalized medicine is making the greatest strides: oncology, in which AstraZeneca is the recognized leader. AstraZeneca already has three blockbuster oncology drugs. Here’s what Morningstar said about these drugs […]
The largest player in mortgage lending announced it has pulled its plans to dominate the home loan industry. That change is positive news for one of my favorite mortgage finance companies and its shares. Let’s take a look at the news, and how to get in… This excerpt comes from an email from Seeking Alpha: […]
Earnings season is upon us, so there tends to be a lot of big options trades as strategists position themselves for the results. 2022 was a rough year for many tech stocks, including Alphabet Class C Shares (GOOG). However, what appears to be a large bullish call spread traded recently in GOOG options. The call […]
With stock prices turning positive over the last few weeks, it’s easy to lose sight of the fact that share prices for many sectors remain down a lot from their early-2022 levels. I was surprised when I recently reviewed some 30-day stock price changes. There remain tremendous, high-yield values in which to invest. Here’s three […]
